Goodwin Procter LLP advised Mirati Therapeutics, Inc. on the deal. Mirati Therapeutics, Inc. (NASDAQ: MRTX) announced its collaboration and license agreement with Zai Lab Limited (NASDAQ:...
Mirati Therapeutics’ Collaboration and License agreement with Zai Lab Limited
Mirati Therapeutics’ Collaboration and License agreement with Zai Lab Limited
Goodwin Procter LLP advised Mirati Therapeutics, Inc. on the deal. Mirati Therapeutics, Inc. (NASDAQ: MRTX) announced its collaboration and license agreement with Zai Lab Limited (NASDAQ:...